BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

Dear Doctor Letter (Rote-Hand-Brief) on Otezla® (apremilast): New important information on suicidal thoughts or behaviour

Active substance: apremilast

The company Celgene GmbH is circulating information regarding occasional cases of suicidal thoughts or behaviour that have been reported from clinical trials and after introduction to the market.

Download DHPC/Information letter , Download_VeroeffentlichtAm_EN PDF, 713KB, File is accessible